Zura Bio ZURA
NASDAQ ZURA
$3.53 -0.61 (-14.65%)
As of: Oct 22, 2026 · 3:59 PM EDT

Zura Bio (ZURA) Debt Ratio (2022)

Updated

Zura Bio's (ZURA) Debt Ratio stood at 1.47 in Q4 2022.

Analysis

Zura Bio (ZURA) Debt Ratio (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 0.39
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.23
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 0.52
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 0.42
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 0.08
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 0.28
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 0.60
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 0.53
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 0.31
10 Zura Bio 454.59 Mn -224.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.47
Sep 30, 2022 0.00
Jun 30, 2022 0.00
API Access

Zura Bio Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ZURA&period=max&api_key=YOUR_API_KEY